Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study.

MLA

Alongi, Pierpaolo, et al. “Choline PET/CT Features to Predict Survival Outcome in High-Risk Prostate Cancer Restaging: A Preliminary Machine-Learning Radiomics Study.” The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society Of., vol. 66, no. 4, Dec. 2022, pp. 352–60. EBSCOhost, https://doi.org/10.23736/S1824-4785.20.03227-6.

APA

Alongi, P., Laudicella, R., Stefano, A., Caobelli, F., Comelli, A., Vento, A., Sardina, D., Ganduscio, G., Toia, P., Ceci, F., Mapelli, P., Picchio, M., Midiri, M., Baldari, S., Lagalla, R., & Russo, G. (2022). Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society Of., 66(4), 352–360. https://doi.org/10.23736/S1824-4785.20.03227-6

Chicago

Alongi, Pierpaolo, Riccardo Laudicella, Alessandro Stefano, Federico Caobelli, Albert Comelli, Antonio Vento, Davide Sardina, et al. 2022. “Choline PET/CT Features to Predict Survival Outcome in High-Risk Prostate Cancer Restaging: A Preliminary Machine-Learning Radiomics Study.” The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society Of. 66 (4): 352–60. doi:10.23736/S1824-4785.20.03227-6.